Biotechnology Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche’s US Facility Acquisition For $1.2B – Roche Holding (OTC:RHHBY) Read more
Stockmarkets Lonza to buy biologics site from Roche in U.S. for $1.2 billion Reuters via biedexmarkets.com Read more